Kusajili – Centralise les essais cliniques mondiaux

Résultat de votre recherche par promoteur : Rüdiger Göke, MD

Femme et Homme Max 99 ans
Rüdiger Göke, MD MAJ Il y a 4 ans

Vildagliptin Versus Sitagliptin - Differences in Fasting Plasma Glucose Lowering Efficacy This study is designed to assess the potential difference in Fasting Plasma Glucose (FPG) lowering efficacy between the two DPP-4 inhibitors vildagliptin and sitagliptin, both after a two ...

Pays Germany
Organes Aucun
Spécialités Aucune

Essai clos aux inclusions

Plus d'informations